United States Biotechnology & Medical Research

Genzyme Corp (GENZ)

Track

Stock chart
Ticker: GENZ Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
SANOFI-AVENTIS
1 purchase — total 1,240,049,089 USD
Buy 8 Apr 2011
Value US$1,345,582.23 | Price 435.69 | Shares 10,723
Sale 31 Aug 2010
Value US$1,513,796.27 | Price 309.23 | Shares 1,193
Planned sale 23 Jul 2010
Value US$1,322,238.75 | Price 63.75 | Shares 20,741
Planned sale 23 Jul 2010
Value US$594,900.00 | Price 66.10 | Shares 9,000
Planned sale 23 Jul 2010
Value US$146,625.00 | Price 63.75 | Shares 2,300
Planned sale 12 Jul 2010
Value US$3,430,809.72 | Price 53.82 | Shares 63,746
Sale 11 Jun 2010
Value US$48,810.00 | Price 48.81 | Shares 1,000
Sale 27 May 2010
Value US$86,050.98 | Price 49.54 | Shares 1,737
Sale 25 May 2010
Value US$124,615.53 | Price 45.63 | Shares 2,731
Planned sale 25 May 2010
Value US$89,923.20 | Price 45.60 | Shares 1,972
Sale 25 May 2010
Value US$1,357,603.20 | Price 45.60 | Shares 29,772
Sale 25 May 2010
Value US$452,687.26 | Price 45.62 | Shares 9,923
Sale 25 May 2010
Value US$89,923.20 | Price 45.60 | Shares 1,972
Sale 25 May 2010
Value US$29,972.34 | Price 45.62 | Shares 657
Sale 25 May 2010
Value US$124,579.20 | Price 45.60 | Shares 2,732
Planned sale 25 May 2010
Value US$231,252.84 | Price 45.63 | Shares 5,068
Planned sale 25 May 2010
Value US$106,179.11 | Price 45.59 | Shares 2,329
Sale 25 May 2010
Value US$304,057.30 | Price 45.62 | Shares 6,665
Sale 25 May 2010
Value US$303,924.00 | Price 45.60 | Shares 6,665
Sale 25 May 2010
Value US$101,367.64 | Price 45.62 | Shares 2,222
Planned sale 25 May 2010
Value US$24,315.46 | Price 45.62 | Shares 533
Sale 25 May 2010
Value US$163,902.96 | Price 45.63 | Shares 3,592
Sale 25 May 2010
Value US$54,607.14 | Price 45.62 | Shares 1,197
Planned sale 24 May 2010
Value US$74,618.25 | Price 48.93 | Shares 1,525
Sale 24 May 2010
Value US$29,015.49 | Price 48.93 | Shares 593
Sale 24 May 2010
Value US$438,168.15 | Price 48.93 | Shares 8,955
Planned sale 21 May 2010
Value US$40,220.46 | Price 48.93 | Shares 822
Planned sale 21 May 2010
Value US$808,901.28 | Price 49.06 | Shares 16,488
Planned sale 17 May 2010
Value US$2,435,390.16 | Price 50.51 | Shares 48,216
Planned sale 17 May 2010
Value US$5,054,000.00 | Price 50.54 | Shares 100,000
Sale 14 May 2010
Value US$928,722.60 | Price 50.70 | Shares 18,318
Sale 4 Mar 2010
Value US$914,496.88 | Price 56.63 | Shares 16,149
Planned sale 22 Feb 2010
Value US$5,578,000.00 | Price 55.78 | Shares 100,000
Planned sale 23 Nov 2009
Value US$10,094,000.00 | Price 50.47 | Shares 200,000
Sale 6 Nov 2009
Value US$1,920,081.25 | Price 52.07 | Shares 36,875
Sale 3 Nov 2009
Value US$50,340.00 | Price 50.34 | Shares 1,000
Buy 10 Sep 2009
Value US$55,000.00 | Price 55.00 | Shares 1,000
Sale 2 Jun 2009
Value US$111,064.82 | Price 61.40 | Shares 1,809
Sale 1 Jun 2009
Value US$148,508.75 | Price 59.40 | Shares 2,500
Planned sale 26 May 2009
Value US$92,785.91 | Price 56.54 | Shares 1,641
Planned sale 26 May 2009
Value US$36,069.46 | Price 56.54 | Shares 638
Planned sale 26 May 2009
Value US$92,779.68 | Price 56.54 | Shares 1,641
Sale 26 May 2009
Value US$544,849.00 | Price 56.54 | Shares 9,637
Planned sale 26 May 2009
Value US$50,036.31 | Price 56.54 | Shares 885
Planned sale 15 May 2009
Value US$86,243.86 | Price 59.40 | Shares 1,452
Planned sale 14 May 2009
Value US$603,277.00 | Price 60.33 | Shares 10,000
Planned sale 13 May 2009
Value US$606,238.00 | Price 60.62 | Shares 10,000
Sale 13 May 2009
Value US$180,570.00 | Price 60.19 | Shares 3,000
Planned sale 12 May 2009
Value US$452,304.36 | Price 60.70 | Shares 7,452
Planned sale 12 May 2009
Value US$154,652.64 | Price 60.70 | Shares 2,548
Planned sale 11 May 2009
Value US$612,775.00 | Price 61.28 | Shares 10,000
Sale 24 Apr 2009
Value US$213,386.40 | Price 53.35 | Shares 4,000
Buy 4 Mar 2009
Value US$38,178.00 | Price 54.54 | Shares 700
Sale 23 Feb 2009
Value US$418,140.00 | Price 69.69 | Shares 6,000
Planned sale 16 Jan 2009
Value US$15,439,970.00 | Price 66.50 | Shares 232,180
Buy 10 Dec 2008
Value US$100,440.00 | Price 64.80 | Shares 1,550
Sale 8 Dec 2008
Value US$3,618,303.57 | Price 65.17 | Shares 55,521
Sale 4 Nov 2008
Value US$835,408.00 | Price 74.59 | Shares 11,200
Planned sale 23 Sep 2008
Value US$2,811,003.55 | Price 76.73 | Shares 36,635
Sale 15 Aug 2008
Value US$1,479,950.10 | Price 83.19 | Shares 17,790
Sale 14 Aug 2008
Value US$1,237,650.00 | Price 82.51 | Shares 15,000
Sale 14 Aug 2008
Value US$1,571,446.72 | Price 81.71 | Shares 19,232
Sale 12 Aug 2008
Value US$2,321,810.00 | Price 79.00 | Shares 29,390
Sale 7 Aug 2008
Value US$847,167.75 | Price 78.99 | Shares 10,725
Sale 6 Aug 2008
Value US$509,155.00 | Price 79.00 | Shares 6,445
Sale 5 Aug 2008
Value US$2,165,358.00 | Price 78.00 | Shares 27,761
Planned sale 15 Jul 2008
Value US$1,470,863.50 | Price 79.70 | Shares 18,455
Planned sale 8 Jul 2008
Value US$1,215,000.00 | Price 75.00 | Shares 16,200
Planned sale 25 Jun 2008
Value US$2,637,720.00 | Price 72.00 | Shares 36,635
Sale 21 May 2008
Value US$1,625,040.00 | Price 67.71 | Shares 24,000
Sale 2 May 2008
Value US$1,908,090.00 | Price 70.67 | Shares 27,000
Sale 3 Mar 2008
Value US$1,439,168.00 | Price 72.32 | Shares 19,900
Planned sale 17 Jan 2008
Value US$3,755,026.00 | Price 82.00 | Shares 45,793
Planned sale 16 Jan 2008
Value US$1,608,425.70 | Price 79.70 | Shares 20,181
Planned sale 16 Jan 2008
Value US$7,200,000.00 | Price 80.00 | Shares 90,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2011-04-08 2011-04-08 B Purchase SANOFI-AVENTIS Large shareholder
10,723 +5.2%
435.69
US$1,345,582 		10,723 +5.2% 435.69 US$1,345,582
2010-09-02 2010-08-31 S Sale Amello Jason

Corp Contrllr,ChiefAccntOfficr

Officer
1,193 -35.5%
309.23
US$1,513,796 		1,193 -35.5% 309.23 US$1,513,796
2010-07-27 2010-07-23 PlS Planned sale SMITH SANDFORD D

Exe VP,President Int'l Group

Officer
33,944 +47.7%
199.73
US$3,500,087 		33,944 +47.7% 199.73 US$3,500,087
2010-07-27 2010-07-23 PlS Planned sale SMITH SANDFORD D

Exe VP,President Int'l Group

Officer
9,000 -17.9%
66.10
US$594,900 		9,000 -17.9% 66.10 US$594,900
2010-07-27 2010-07-23 PlS Planned sale SMITH SANDFORD D

Exe VP,President Int'l Group

Officer
2,300 -4.4%
63.75
US$146,625 		2,300 -4.4% 63.75 US$146,625
2010-07-14 2010-07-12 PlS Planned sale CSIMMA ZOLTAN A

SrVP,Chief Human Resources Off

Officer
63,746 -83.4%
53.82
US$3,430,810 		63,746 -83.4% 53.82 US$3,430,810
2010-06-15 2010-06-11 S Sale GERAGHTY JAMES A

Senior Vice President

Officer
1,000 -18.7%
48.81
US$48,810 		1,000 -18.7% 48.81 US$48,810
2010-06-01 2010-05-27 S Sale SMITH ALAN E

Sr VP,Chief Scientific Officer

Officer
1,737 -4.5%
49.54
US$86,051 		1,737 -4.5% 49.54 US$86,051
2010-05-26 2010-05-25 S Sale MOSCICKI RICHARD A

Sr VP,Chief Medical Officer

Officer
2,731 -11.6%
45.63
US$124,616 		2,731 -11.6% 45.63 US$124,616
2010-05-26 2010-05-25 PlS Planned sale DesRosier Thomas

Sr VP, General Counsel

Officer
1,972 -27.1%
45.60
US$89,923 		1,972 -27.1% 45.60 US$89,923
2010-05-26 2010-05-25 S Sale TERMEER HENRI A

Chmn, President and CEO

Executive Director
29,772 -4.2%
45.60
US$1,357,603 		29,772 -4.2% 45.60 US$1,357,603
2010-05-26 2010-05-25 S Sale TERMEER HENRI A

Chmn, President and CEO

Executive Director
9,923 -1.4%
45.62
US$452,687 		9,923 -1.4% 45.62 US$452,687
2010-05-26 2010-05-25 S Sale CSIMMA ZOLTAN A

SrVP,Chief Human Resources Off

Officer
1,972 -13.6%
45.60
US$89,923 		1,972 -13.6% 45.60 US$89,923
2010-05-26 2010-05-25 S Sale CSIMMA ZOLTAN A

SrVP,Chief Human Resources Off

Officer
657 -4.3%
45.62
US$29,972 		657 -4.3% 45.62 US$29,972
2010-05-26 2010-05-25 S Sale Meeker David P

ExecVP,Chief Operating Officer

Officer
2,732 -21.4%
45.60
US$124,579 		2,732 -21.4% 45.60 US$124,579
2010-05-26 2010-05-25 PlS Planned sale WYZGA MICHAEL S

Executive VP and CFO

Officer
5,068 -17.4%
45.63
US$231,253 		5,068 -17.4% 45.63 US$231,253
2010-05-26 2010-05-25 PlS Planned sale GERAGHTY JAMES A

Senior Vice President

Officer
2,329 -30.3%
45.59
US$106,179 		2,329 -30.3% 45.59 US$106,179
2010-05-26 2010-05-25 S Sale WIRTH PETER

Exec VP,Legal & Corporate Dev.

Officer
6,665 -30.5%
45.62
US$304,057 		6,665 -30.5% 45.62 US$304,057
2010-05-26 2010-05-25 S Sale SMITH SANDFORD D

Exe VP,President Int'l Group

Officer
6,665 -24.4%
45.60
US$303,924 		6,665 -24.4% 45.60 US$303,924
2010-05-26 2010-05-25 S Sale SMITH SANDFORD D

Exe VP,President Int'l Group

Officer
2,222 -7.5%
45.62
US$101,368 		2,222 -7.5% 45.62 US$101,368
2010-05-26 2010-05-25 PlS Planned sale Amello Jason

CorpContrllr,ChiefAccntOfficer

Officer
533 -14.0%
45.62
US$24,315 		533 -14.0% 45.62 US$24,315
2010-05-26 2010-05-25 S Sale SMITH ALAN E

Sr VP,Chief Scientific Officer

Officer
3,592 -8.4%
45.63
US$163,903 		3,592 -8.4% 45.63 US$163,903
2010-05-26 2010-05-25 S Sale SMITH ALAN E

Sr VP,Chief Scientific Officer

Officer
1,197 -2.7%
45.62
US$54,607 		1,197 -2.7% 45.62 US$54,607
2010-05-25 2010-05-24 PlS Planned sale SMITH SANDFORD D

Exe VP,President Int'l Group

Officer
1,525 -13.8%
48.93
US$74,618 		1,525 -13.8% 48.93 US$74,618
2010-05-25 2010-05-24 S Sale CSIMMA ZOLTAN A

SrVP,Chief Human Resources Off

Officer
593 -7.4%
48.93
US$29,015 		593 -7.4% 48.93 US$29,015
2010-05-25 2010-05-24 S Sale TERMEER HENRI A

Chmn,President and CEO

Executive Director
8,955 -1.4%
48.93
US$438,168 		8,955 -1.4% 48.93 US$438,168
2010-05-25 2010-05-21 PlS Planned sale SMITH ALAN E

Sr VP,Chief Scientific Officer

Officer
822 -2.4%
48.93
US$40,220 		822 -2.4% 48.93 US$40,220
2010-05-25 2010-05-21 PlS Planned sale Meeker David P

ExecVP,Chief Operating Officer

Officer
16,488 -77.8%
49.06
US$808,901 		16,488 -77.8% 49.06 US$808,901
2010-05-19 2010-05-17 PlS Planned sale WIRTH PETER

Exec VP,Legal & Corporate Dev.

Officer
48,216 -87.6%
50.51
US$2,435,390 		48,216 -87.6% 50.51 US$2,435,390
2010-05-19 2010-05-17 PlS Planned sale TERMEER HENRI A

Chmn, President and CEO

Executive Director
100,000 -13.8%
50.54
US$5,054,000 		100,000 -13.8% 50.54 US$5,054,000
2010-05-18 2010-05-14 S Sale MOSCICKI RICHARD A

Sr VP,Chief Medical Officer

Officer
18,318 -54.2%
50.70
US$928,723 		18,318 -54.2% 50.70 US$928,723
2010-03-08 2010-03-04 S Sale SMITH ALAN E

Sr VP,Chief Scientific Officer

Officer
16,149 -34.2%
56.63
US$914,497 		16,149 -34.2% 56.63 US$914,497
2010-02-24 2010-02-22 PlS Planned sale TERMEER HENRI A

Chmn, President and CEO

Executive Director
100,000 -13.8%
55.78
US$5,578,000 		100,000 -13.8% 55.78 US$5,578,000
2009-11-25 2009-11-23 PlS Planned sale TERMEER HENRI A

Chmn, President and CEO

Executive Director
200,000 -24.3%
50.47
US$10,094,000 		200,000 -24.3% 50.47 US$10,094,000
2009-11-10 2009-11-06 S Sale GERAGHTY JAMES A

Senior Vice President

Officer
36,875 -94.0%
52.07
US$1,920,081 		36,875 -94.0% 52.07 US$1,920,081
2009-11-05 2009-11-03 S Sale COONEY CHARLES L Non-Executive Director
1,000 -12.2%
50.34
US$50,340 		1,000 -12.2% 50.34 US$50,340
2009-09-14 2009-09-10 B Purchase DZAU VICTOR J Non-Executive Director
1,000 +64.5%
55.00
US$55,000 		1,000 +64.5% 55.00 US$55,000
2009-06-03 2009-06-02 S Sale SMITH ALAN E

Sr VP,Chief Scientific Officer

Officer
1,809 -5.6%
61.40
US$111,065 		1,809 -5.6% 61.40 US$111,065
2009-06-03 2009-06-01 S Sale COONEY CHARLES L Non-Executive Director
2,500 -23.4%
59.40
US$148,509 		2,500 -23.4% 59.40 US$148,509
2009-05-27 2009-05-26 PlS Planned sale SMITH SANDFORD D

Exe VP,President Int'l Group

Officer
1,641 -15.0%
56.54
US$92,786 		1,641 -15.0% 56.54 US$92,786
2009-05-27 2009-05-26 PlS Planned sale CSIMMA ZOLTAN A

SrVP,Chief Human Resources Off

Officer
638 -10.2%
56.54
US$36,069 		638 -10.2% 56.54 US$36,069
2009-05-27 2009-05-26 PlS Planned sale COLLIER EARL M JR

Executive Vice President

Officer
1,641 -22.9%
56.54
US$92,780 		1,641 -22.9% 56.54 US$92,780
2009-05-27 2009-05-26 S Sale TERMEER HENRI A

Chmn, President and CEO

Executive Director
9,637 -1.5%
56.54
US$544,849 		9,637 -1.5% 56.54 US$544,849
2009-05-27 2009-05-26 PlS Planned sale SMITH ALAN E

Sr VP,Chief Scientific Officer

Officer
885 -2.6%
56.54
US$50,036 		885 -2.6% 56.54 US$50,036
2009-05-18 2009-05-15 PlS Planned sale CARPENTER ROBERT J Non-Executive Director
1,452 -4.9%
59.40
US$86,244 		1,452 -4.9% 59.40 US$86,244
2009-05-18 2009-05-14 PlS Planned sale CARPENTER ROBERT J Non-Executive Director
10,000 -26.3%
60.33
US$603,277 		10,000 -26.3% 60.33 US$603,277
2009-05-14 2009-05-13 PlS Planned sale CARPENTER ROBERT J Non-Executive Director
10,000 -26.3%
60.62
US$606,238 		10,000 -26.3% 60.62 US$606,238
2009-05-14 2009-05-13 S Sale COONEY CHARLES L Non-Executive Director
3,000 -26.9%
60.19
US$180,570 		3,000 -26.9% 60.19 US$180,570
2009-05-13 2009-05-12 PlS Planned sale CARPENTER ROBERT J Non-Executive Director
7,452 -21.0%
60.70
US$452,304 		7,452 -21.0% 60.70 US$452,304
2009-05-13 2009-05-12 PlS Planned sale CARPENTER ROBERT J Non-Executive Director
2,548 -6.7%
60.70
US$154,653 		2,548 -6.7% 60.70 US$154,653
2009-05-13 2009-05-11 PlS Planned sale CARPENTER ROBERT J Non-Executive Director
10,000 -26.3%
61.28
US$612,775 		10,000 -26.3% 61.28 US$612,775
2009-04-28 2009-04-24 S Sale COONEY CHARLES L Non-Executive Director
4,000 -26.4%
53.35
US$213,386 		4,000 -26.4% 53.35 US$213,386
2009-03-06 2009-03-04 B Purchase Bamforth Mark R

Sr.VP, Corp. Operations & Phar

Officer
700 +22.8%
54.54
US$38,178 		700 +22.8% 54.54 US$38,178
2009-02-25 2009-02-23 S Sale COONEY CHARLES L Non-Executive Director
6,000 -28.4%
69.69
US$418,140 		6,000 -28.4% 69.69 US$418,140
2009-01-20 2009-01-16 PlS Planned sale WIRTH PETER

Exec VP,Legal & Corporate Dev.

Officer
232,180 -97.5%
66.50
US$15,439,970 		232,180 -97.5% 66.50 US$15,439,970
2008-12-12 2008-12-10 B Purchase DZAU VICTOR J Non-Executive Director
1,550 +inf%
64.80
US$100,440 		1,550 +inf% 64.80 US$100,440
2008-12-10 2008-12-08 S Sale SMITH ALAN E

Sr VP,Chief Scientific Officer

Officer
55,521 -64.5%
65.17
US$3,618,304 		55,521 -64.5% 65.17 US$3,618,304
2008-11-05 2008-11-04 S Sale BERTHIAUME DOUGLAS A Non-Executive Director
11,200 -14.5%
74.59
US$835,408 		11,200 -14.5% 74.59 US$835,408
2008-09-25 2008-09-23 PlS Planned sale MOSCICKI RICHARD A

Sr VP,Chief Medical Officer

Officer
36,635 -70.3%
76.73
US$2,811,004 		36,635 -70.3% 76.73 US$2,811,004
2008-08-18 2008-08-15 S Sale Meeker David P

President LSD Therapeutics

Officer
17,790 -90.4%
83.19
US$1,479,950 		17,790 -90.4% 83.19 US$1,479,950
2008-08-15 2008-08-14 S Sale SMITH ALAN E

Senior Vice President

Officer
15,000 -33.0%
82.51
US$1,237,650 		15,000 -33.0% 82.51 US$1,237,650
2008-08-15 2008-08-14 S Sale Bamforth Mark R

Sr.VP, Corp. Operations & Phar

Officer
19,232 -99.2%
81.71
US$1,571,447 		19,232 -99.2% 81.71 US$1,571,447
2008-08-13 2008-08-12 S Sale WYZGA MICHAEL S

Executive VP and CFO

Officer
29,390 -69.0%
79.00
US$2,321,810 		29,390 -69.0% 79.00 US$2,321,810
2008-08-08 2008-08-07 S Sale DesRosier Thomas

Sr VP General Counsel

Officer
10,725 -93.7%
78.99
US$847,168 		10,725 -93.7% 78.99 US$847,168
2008-08-07 2008-08-06 S Sale Bamforth Mark R

Sr.VP, Corp. Operations & Phar

Officer
6,445 -97.6%
79.00
US$509,155 		6,445 -97.6% 79.00 US$509,155
2008-08-06 2008-08-05 S Sale SMITH ALAN E

Senior Vice President

Officer
27,761 -47.7%
78.00
US$2,165,358 		27,761 -47.7% 78.00 US$2,165,358
2008-07-17 2008-07-15 PlS Planned sale SMITH ALAN E

Senior Vice President

Officer
18,455 -37.7%
79.70
US$1,470,864 		18,455 -37.7% 79.70 US$1,470,864
2008-07-10 2008-07-08 PlS Planned sale COLLIER EARL M JR

Executive Vice President

Officer
16,200 -89.2%
75.00
US$1,215,000 		16,200 -89.2% 75.00 US$1,215,000
2008-06-27 2008-06-25 PlS Planned sale MOSCICKI RICHARD A

Senior Vice President

Officer
36,635 -70.3%
72.00
US$2,637,720 		36,635 -70.3% 72.00 US$2,637,720
2008-05-23 2008-05-21 S Sale BERTHIAUME DOUGLAS A Non-Executive Director
24,000 -23.7%
67.71
US$1,625,040 		24,000 -23.7% 67.71 US$1,625,040
2008-05-06 2008-05-02 S Sale COONEY CHARLES L Non-Executive Director
27,000 -56.1%
70.67
US$1,908,090 		27,000 -56.1% 70.67 US$1,908,090
2008-03-05 2008-03-03 S Sale MCGILLICUDY CORNELIUS III Non-Executive Director
19,900 -100.0%
72.32
US$1,439,168 		19,900 -100.0% 72.32 US$1,439,168
2008-01-22 2008-01-17 PlS Planned sale MOSCICKI RICHARD A

Senior Vice President

Officer
45,793 -74.7%
82.00
US$3,755,026 		45,793 -74.7% 82.00 US$3,755,026
2008-01-18 2008-01-16 PlS Planned sale SMITH SANDFORD D

Executive Vice President

Officer
20,181 -79.2%
79.70
US$1,608,426 		20,181 -79.2% 79.70 US$1,608,426
2008-01-18 2008-01-16 PlS Planned sale COLLIER EARL M JR

Executive Vice President

Officer
90,000 -97.4%
80.00
US$7,200,000 		90,000 -97.4% 80.00 US$7,200,000
Explore more

More insider trading research around Genzyme Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America